{"id":247644,"date":"2026-11-18T03:25:11","date_gmt":"2026-11-18T09:25:11","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/11\/experimental-blood-test-can-detect-four-signs-of-deadly-diseases-in-an-hour"},"modified":"2026-11-18T03:25:11","modified_gmt":"2026-11-18T09:25:11","slug":"experimental-blood-test-can-detect-four-signs-of-deadly-diseases-in-an-hour","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/11\/experimental-blood-test-can-detect-four-signs-of-deadly-diseases-in-an-hour","title":{"rendered":"Experimental blood test can detect four signs of deadly diseases in an hour"},"content":{"rendered":"\n<p>A new diagnostic platform is able to screen for and identify four different diseases\u2014colorectal cancer, glioblastoma, pancreatic cancer and Alzheimer\u2019s disease\u2014with a small amount of blood in an hour. The patent-pending technology was developed by a team of researchers led by Hsueh-Chia Chang at the University of Notre Dame.<\/p>\n<p>The diagnostic platform was tested in a blind setting using 87 plasma samples from blood draws from patients who were either healthy or had one of the four diseases. The platform was found to be 90% to 99% accurate for detecting the presence or absence of each disease type.<\/p>\n<p>\u201cWe believe that if we can screen these diseases earlier, then patients may have a better chance at surviving,\u201d said Chang, the Bayer Corporation professor of engineering in the Department of Chemical and Biomolecular Engineering at Notre Dame. The study is <a href=\"https:\/\/www.nature.com\/articles\/s41551-026-01632-8\" target=\"_blank\">published<\/a> in Nature Biomedical Engineering.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A new diagnostic platform is able to screen for and identify four different diseases\u2014colorectal cancer, glioblastoma, pancreatic cancer and Alzheimer\u2019s disease\u2014with a small amount of blood in an hour. The patent-pending technology was developed by a team of researchers led by Hsueh-Chia Chang at the University of Notre Dame. The diagnostic platform was tested in [\u2026]<\/p>\n","protected":false},"author":427,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,19,38,47],"tags":[],"class_list":["post-247644","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-chemistry","category-engineering","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/247644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/427"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=247644"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/247644\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=247644"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=247644"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=247644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}